Overview
Vesicular stomatitis virus (VSV) disease is a viral infection characterized by the development of vesicular lesions, typically affecting the oral mucosa, tongue, lips, and sometimes the hooves of animals, particularly pigs and cattle. It is clinically significant due to its potential to cause significant morbidity, economic losses in livestock farming, and, though rare, occasional zoonotic transmission to humans. The disease is primarily endemic in regions such as North and South America but can emerge in other areas due to animal movement. Understanding VSV disease is crucial for clinicians involved in veterinary medicine and public health, as early recognition and intervention can mitigate its spread and impact 8.Pathophysiology
VSV, a member of the Rhabdoviridae family, replicates within host cells, particularly those lining mucosal surfaces, leading to cell lysis and the formation of vesicular lesions. The virus enters cells via receptor-mediated endocytosis, primarily through the VSV glycoprotein (G), which binds to specific cell surface receptors. Once inside, the virus hijacks the host cell machinery to produce viral proteins and RNA, leading to assembly and release of new virions. This cycle of infection and replication disrupts normal cellular functions, resulting in inflammation and the characteristic vesicular lesions. The immune response, including both innate and adaptive immunity, plays a critical role in controlling the infection, but severe cases can overwhelm this response, exacerbating tissue damage 8.Epidemiology
VSV disease has varying incidence rates depending on geographic location and animal population density. In endemic regions like parts of the Americas, outbreaks can occur seasonally, particularly during warmer months when conditions favor viral transmission. Pigs and cattle are predominantly affected, with young animals being more susceptible due to less developed immune systems. Human cases are rare but can occur, especially among individuals in close contact with infected animals. Epidemiological trends suggest that improved biosecurity measures and vaccination programs have helped reduce the frequency and severity of outbreaks in controlled settings. However, sporadic outbreaks still pose significant public health and veterinary concerns 8.Clinical Presentation
The clinical presentation of VSV disease in animals typically includes fever, lethargy, and the development of painful vesicular lesions. In pigs, lesions often appear on the snout, tongue, and coronary bands of hooves, while cattle may exhibit lesions on the muzzle, tongue, and teats. Humans, when affected, usually present with flu-like symptoms followed by painful oral or dermal vesicles. Red-flag features include rapid progression of lesions, high fever, and signs of systemic illness, which may indicate a more severe infection requiring prompt intervention. Accurate clinical assessment is crucial for timely diagnosis and management 8.Diagnosis
Diagnosis of VSV disease involves a combination of clinical signs and laboratory tests. Key diagnostic approaches include:Specific Criteria and Tests:
Management
First-Line Treatment
Specifics:
Second-Line Treatment
Specifics:
Refractory Cases
Specifics:
Complications
Management Triggers:
Prognosis & Follow-Up
The prognosis for VSV disease generally improves with timely intervention and supportive care. Prognostic indicators include the rapidity of lesion healing, absence of secondary infections, and effective immune response. Follow-up intervals should include:Recommended Intervals:
Special Populations
Pediatrics and Young Animals
Elderly or Immunocompromised Animals
Key Recommendations
References
1 Huang J, Zhou H, Hu Z, Xie F, Wen X, Ran X. A lyophilized stabilizer formulation enhances thermostability and preserves the immunogenicity of Senecavirus A post thermal challenge. Journal of virological methods 2026. link 2 Kang S, Jeon S, Baek H, Hwang S, Kim S, Youn SH et al.. (no title). Biomaterials science 2025. link 3 José Sánchez M, Leivar P, Borrós S, Fornaguera C, Lecina M. Enhanced quantification and cell tracking of dual fluorescent labeled extracellular vesicles. International journal of pharmaceutics 2024. link 4 Yang S, Qin W, Li X, Guo Q, Wang Y, Chen J et al.. A cryostat-based frozen section method to increase the yield of extracellular vesicles extracted from different tissues. BioTechniques 2022. link 5 Yuan F, Li YM, Wang Z. Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation. Drug delivery 2021. link 6 Lannigan J, Erdbruegger U. Imaging flow cytometry for the characterization of extracellular vesicles. Methods (San Diego, Calif.) 2017. link 7 Freire M, Boyde A. Study of Golgi-impregnated material using the confocal tandem scanning reflected light microscope. Journal of microscopy 1990. link 8 Garland JM, Mann JA. Attemps to infect pigs with Coxsackie virus type B5. The Journal of hygiene 1974. link